Vasculitis and Giant Cell Arteritis News

Despite an ever-growing array of potential candidate biomarkers for antineutrophil cytoplasmic antibody-associated vasculitis, it can be a long journey from “bench work” to bedside, according to a presenter at ACR Convergence 2021.

Patients with VEXAS syndrome who were blood transfusion dependent or had a variant of the valine gene exhibited a threefold increased risk for mortality, according to data presented at ACR Convergence 2021.

Patients with ANCA-associated vasculitis who received avacopan showed greater recovery of kidney function compared with patients who received prednisone, according to study results presented at ASN Kidney Week.

Eye exam reminders at every visit are associated with higher uveitis knowledge among patients with juvenile idiopathic arthritis and their parents, according to data published in Pediatric Rheumatology.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

The FDA has approved avacopan as an adjunctive treatment for adults with severe active ANCA-associated vasculitis, specifically granulomatosis with polyangiitis and microscopic polyangiitis, alongside standard therapy.

Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to data published in Arthritis Care & Research.

Understanding the difference between scleritis and episcleritis is critical to minimizing eye pain and, potentially, preserving a patient’s vision, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

A trio of recent clinical trials showed encouraging results for steroid-sparing strategies in ANCA-associated vasculitis, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

In a disturbing repeat of last year’s run on hydroxychloroquine, U.S. health care systems are scrambling to maintain tocilizumab access for rheumatology patients following the drug’s emergency use authorization for COVID-19 and the surge in delta variant cases.